A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
作者:
主题词
药物副反应报告系统(Adverse Drug Reaction Reporting Systems);年龄因素(Age Factors);老年人(Aged);老年人, 80以上(Aged, 80 and over);氮杂双环化合物(Azabicyclo Compounds);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);催眠药和镇静药(Hypnotics and Sedatives);男(雄)性(Male);病人满意度(Patient Satisfaction);哌嗪类(Piperazines);睡眠(Sleep);入睡和睡眠障碍(Sleep Initiation and Maintenance Disorders);治疗结果(Treatment Outcome);觉醒状态(Wakefulness)
DOI
10.1093/sleep/33.2.225
PMID
20175406
发布时间
2021-10-20
- 浏览30

Sleep
225-34页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文